SEC Form 4 · accession 0001140361-26-029185
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura Piccinini
Officer — SVP International
Period of report
Jul 16, 2026
Accepted (ET)
Jul 21, 2026 · 8:28 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 16, 2026 | F | 4,538 | $14.14 | D | 62,218 | D | |
| Common StockF2 | Jul 17, 2026 | F | 3,074 | $13.51 | D | 59,144 | D | |
| Common StockF3 | Jul 20, 2026 | F | 616 | $13.71 | D | 58,528 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The exempt disposition of 4,538 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.
- F2The exempt disposition of 3,074 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
- F3The exempt disposition of 616 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.